FDA risk management “toolkit” meeting
Executive Summary
FDA plans to hold a public hearing on drug risk management tools in May. FDA and the Pharmaceutical Research & Manufacturers of America met privately in October and November to begin developing risk management "toolkit" options (1"The Pink Sheet" Dec. 17, 2001, p. 28)...
You may also be interested in...
Pfizer “Toolkit” Proposal Focuses On Adverse Event Signals
Pfizer is proposing that the PhRMA/FDA "toolkit" working group focus on methods to gather more reliable signals of adverse events as a precursor to an improved risk management system
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.